Phil K. Hopper

DVI Inc. provides medical procedures such as diagnostic imaging and radiation therapy. The company conducts its business principally through two operating subsidiaries DVI Financial Services Inc and DVI Business Credit Corporation. The company was founded in 1986 and is located in Jamison, PA.

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

Palo Alto Investors LLC (PAI) is a registered investment advisor and hedge fund manager headquartered in Palo Alto, California. The firm was founded by William L. Edwards in 1989 as Palo Alto Investors LLC and converted into a California limited partnership in 2018. They are a subsidiary of PAI LLC. PAI serves as the investment adviser to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

CathRx Ltd. manufactures and develops electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias. Its products include ablation EP catheters, loop EP catheters, steerable EP catheters, and fixed EP catheters. The company was founded on 31st August, 1999 and is headquartered in Homebush Bay, Australia.

Coherex Medical, Inc. designs, develops, and markets catheter-based technologies for the treatment of structural heart defects. It offers WaveCrest device that is placed in the opening of the left atrial appendage to reduce complications associated with other device types, as well as simplifies the implant procedures. The company was founded by Brian K. Whisenant and Clark C. Davis in 2003 and is headquartered in Salt Lake City, UT.

Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of Johnson & Johnson, Atrionix, Inc. is a company that develops a proprietary, catheter-based system for the treatment of atrial fibrillation. The company is based in Palo Alto, CA. The company was founded by James C. Peacock. Atrionix was acquired by Cordis Corp. on December 27, 2000 for $62.80 million.

Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne.

CardioFocus, Inc. engages in the development and market of catheter-based approach to treating atrial fibrillation. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.

De Novo Ventures LLC (De Novo ventures) is a venture capital firm founded in 2000 by Frederick Dotzler, Richard Ferrari and David Mauney. The firm is headquartered in Menlo Park, California.

Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA.

X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ.

Medtronic CardioVascular manufactures medical devices. Its products include dru-eluting stents, guide catheters, guidewires and balloon diagnostic catheters to treat diabetes, heart disease, neurological disorders and vascular illnesses. The company is headquartered in Santa Rosa, CA.

SmartPill Diagnostic, Inc. manufactures ingestible, capsule-based medical devices for gastrointestinal disorders and diseases. The firm product is SmartPill GI Monitoring System that assist physicians and researchers in the evaluation of gastroparesis and chronic constipation, GI motility disorders . The company was founded in 1999 and is headquartered in Buffalo, NY.

Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX.

Allied Minds LLC (Allied Minds) is a venture capital subsidiary of Allied Minds Plc founded in 2006 by Mark A. Pritchard. The firm is headquartered in Boston, Massachusetts.

Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA.

Precision Biopsy LLC develops medical device platform. It also develops a medical device platform to provide real-time identification of normal prostate tissue, optimize diagnosis, minimize unnecessary tissue coring, pathology costs and patient anxiety. The company was founded by John W. Daily and Priya N. Werahera in 2008 and is headquartered in Aurora, CO.

Propel Careers is a life science search and career development firm that offers job placement, networking events, and mentorship programs. The private company is based in Boston, MA, and was founded by Omar Amirana. Propel Careers works with innovative organizations in the Boston area and life sciences hubs to hire top talent for a range of positions. The company's mission is to enable the critical human resource connections required to advance the life science industry as a whole as well as the growth and advancement of the companies and individuals they work with. Propel Careers has a scientific background and experience in career coaching and mentoring, which gives the team a holistic understanding of the needs of job seekers and the various questions they may have as they navigate their search.

N8 Medical, Inc. is an American clinical stage biotechnology company that develops anti-fouling medical devices to reduce infections, complications, and mortality. The private company is based in an undisclosed location and has a platform technology called Cerashield™, which is based on ceragenins, a novel compound invented by Professor Paul B. Savage. The technology has been featured in over 90 peer-reviewed journal articles. Marc H. Rohman has been the CEO of the company since 2019.

Koch Disruptive Technologies LLC (Koch Disruptive Technologies) is a venture capital firm subsidiary of Koch Industries Inc founded in 2017. The firm is headquartered in Wichita, Kansas.